Lung infections in Influenza-Like Illness (ILI) are triggered by a variety of respiratory viruses.
All human pandemics have been caused by the members of two major virus families …

Influenza virus continuously evolves to escape human adaptive immunity and generates
seasonal epidemics. Therefore, influenza vaccine strains need to be updated annually for …

The receptor-binding site of influenza A virus hemagglutinin partially overlaps with major
antigenic sites and constantly evolves. In this study, we observe that mutations G186D and …

During influenza virus entry, the hemagglutinin (HA) protein binds receptors and causes
membrane fusion after endosomal acid activation. To improve vaccine efficiency and …

Antigenic characterization of circulating influenza A virus (IAV) isolates is routinely assessed
by using the hemagglutination inhibition (HI) assays for surveillance purposes. It is also …

As one of the most effective measures to prevent seasonal influenza viruses, annual
influenza vaccination is globally recommended. Nevertheless, evidence regarding the …

We report the seroprevalence to the circulating influenza A H1N1 and H3N2 viruses from
plasma samples collected from 479 adults between 2021 and 2022. Our results show that …

Influenza A virus (IAV) is one of the major causative agents of acute respiratory infections in
humans. Influenza disease causes up to 650,000 deaths every year with its burden highest …

Influenza A virus (IAV) is one of the major causative agents of acute respiratory infections in
humans. Influenza disease causes up to 650,000 deaths every year with its burden highest …

Influenza vaccine viruses are predominantly grown in embryonated hens-eggs. A (H3N2)
viruses commonly adapt to growth in eggs by substituting hemagglutinin positions G186V or …